Author:
Iino Yuchi,Takai Yoshiki,Ando Tatsumasa,Sugamata Noritaka,Maemura Michio,Takeo Takeshi,Ohwada Susumu,Morishita Yasuo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference28 articles.
1. Campen CA, Jordan VC, Gorski J(1985) Opposing biological action of antiestrogens in vitro and in vivo: induction of progesterone receptor in mouse uterus. Endocrinology 116:2327
2. Dickson RB, McManaway ME, Lippman ME (1986) Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science 232:1540
3. Furr BJA, Jordan VC (1984) The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25:127
4. Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC (1988) Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athmic mouce. Cancer Res 48:812
5. Hietanen T, Baltina D, Johansson R, Numminen S, Hakala T, Helle L, Valavaara R (1990) High dose toremifene (240 mg daily) is effective as first line hormonal treatment in advanced breast cancer. An ongoing phase II multicenter Finnish-Latvian cooperative study. Breast Cancer Res Treat 16 [Suppl]:S37
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献